Elisheva Lew
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A Method for Adjusting EQ-5D-3L Health State Utilities for Cross-Country Use: Application of a Novel US-to-UK Utility Mapping Approach.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: April 29, 2025
A Vignette Study to Derive Health-Related Quality-of-Life Weights for Individuals with Steroid Refractory Chronic Graft-versus-Host Disease Receiving Third-Line Therapy in the United Kingdom.
Journal: Journal of health economics and outcomes research
Published: August 14, 2024
Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study.
Journal: Diabetes spectrum : a publication of the American Diabetes Association
Published: August 16, 2023
iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world study.
Journal: Diabetes, obesity & metabolism
Published: October 28, 2022
Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: May 18, 2022
Improved patient-reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial.
Journal: Diabetes, obesity & metabolism
Published: April 26, 2022
Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UK.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 24, 2022
Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 04, 2021
Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 04, 2021
Characterization of uncontrolled, severe asthma patients with type 2 inflammation (T2): results from a physician survey across countries from Latin American, Eurasian Middle East regions and China.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: March 24, 2021
Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real-world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN).
Journal: Endocrinology, diabetes & metabolism
Published: July 08, 2019
The Use of Computer Simulation Modeling to Estimate Complications in Patients with Type 2 Diabetes Mellitus: Comparative Validation of the Cornerstone Diabetes Simulation Model.
Journal: PharmacoEconomics - open
Published: June 30, 2019
Last Updated: 09/26/2026